IPO Year:
Exchange: NASDAQ
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/8/2025 | $25.00 | Overweight | Cantor Fitzgerald |
| 10/7/2024 | $20.00 | Buy | Guggenheim |
| 9/24/2024 | $17.00 | Mkt Outperform | JMP Securities |
| 9/24/2024 | $18.00 → $25.00 | Buy | Maxim Group |
| 4/2/2024 | $12.00 → $18.00 | Buy | Maxim Group |
| 3/12/2024 | Outperform | William Blair | |
| 3/17/2023 | $12.00 | Buy | Maxim Group |
4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)
4 - ZEVRA THERAPEUTICS, INC. (0001434647) (Issuer)